13F filer · CIK 1595725
Rock Springs Capital Management LP
Baltimore, MD · filing since Q4 2013 · last filing Aug 14, 2026
Reported value
$2.0B
+$352.2M vs prior
Positions
104
New / sold out
17 / 13
Added / reduced
40 / 30
Turnover
13.7%
buys $256.1M · sells $263.1M
Top-10 weight
44.0%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ASCENDIS PHARMA A/S | +168,750 | – | +$45.0M |
| Added | TRAVERE THERAPEUTICS INC | +701,115 | +47.4% | +$39.8M |
| New | AVALYN PHARMACEUTICALS INC | +662,918 | – | +$21.8M |
| New | HEMAB THERAPEUTICS HLDGS INC | +575,432 | – | +$21.1M |
| New | PARABILIS MEDICINES INC | +578,028 | – | +$15.8M |
| Added | CYTOKINETICS INC | +142,616 | +314.4% | +$12.1M |
| Added | MINIMED GROUP INC | +465,000 | +44.1% | +$7.0M |
| New | OMEROS CORP | +718,499 | – | +$6.8M |
| New | DEFINIUM THERAPEUTICS INC | +143,187 | – | +$6.7M |
| New | MOBIA MED INC | +418,200 | – | +$5.6M |
47 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | ASCENDIS PHARMA A/S | -194,000 | -100.0% | $-44.4M |
| Reduced | ARGENX SE | -45,750 | -46.4% | $-42.4M |
| Reduced | REVOLUTION MEDICINES INC | -104,255 | -8.6% | $-19.5M |
| Sold out | ARCELLX INC | -169,859 | -100.0% | $-19.5M |
| Reduced | ENLIVEN THERAPEUTICS INC | -361,875 | -43.8% | $-18.4M |
| Sold out | CENTESSA PHARMACEUTICALS PLC | -351,828 | -100.0% | $-14.0M |
| Reduced | AGIOS PHARMACEUTICALS INC | -266,600 | -33.4% | $-9.9M |
| Sold out | SOLENO THERAPEUTICS INC | -257,253 | -100.0% | $-8.6M |
| Reduced | ULTRAGENYX PHARMACEUTICAL IN | -250,918 | -20.6% | $-8.4M |
| Sold out | REGENERON PHARMACEUTICALS | -10,100 | -100.0% | $-7.8M |
33 more rows. Subscribe for $29/month to see every row, download the data and use the API.
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | REVOLUTION MEDICINES INCCOM | 1,105,210 | $207.0M | 10.10% |
| 2 | TRAVERE THERAPEUTICS INCCOM | 2,179,069 | $123.8M | 6.04% |
| 3 | LLYELI LILLY & CO | 98,700 | $118.4M | 5.78% |
| 4 | MADRIGAL PHARMACEUTICALS INCCOM | 174,999 | $94.0M | 4.59% |
| 5 | MIRUM PHARMACEUTICALS INCCOM | 798,145 | $93.4M | 4.56% |
| 6 | RHYTHM PHARMACEUTICALS INCCOM | 692,598 | $76.9M | 3.75% |
| 7 | KYMERA THERAPEUTICS INCCOM | 453,156 | $52.0M | 2.54% |
| 8 | ARGENX SESPONSORED ADR | 52,750 | $48.9M | 2.39% |
| 9 | ASCENDIS PHARMA A/SORD SHS | 168,750 | $45.0M | 2.20% |
| 10 | XENON PHARMACEUTICALS INCCOM | 683,907 | $41.3M | 2.01% |
94 more rows. Subscribe for $29/month to see every row, download the data and use the API.